Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.86 USD
Change Today -0.0055 / -0.19%
Volume 2.1M
ATHX On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 3:29 PM 03/26/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert J. Deans Ph.D.

Executive Vice President of Regenerative Medicine, Athersys, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

63$611,453
As of Fiscal Year 2014

Background*

Dr. Robert J. Deans, Ph.D. has been an Executive Vice President of Regenerative Medicine at Athersys, Inc., since 2011 (formerly, BTHC VI, Inc.) and served as its Senior Vice President of Regenerative Medicine since June 2006. Dr. Deans served as Vice President of Regenerative Medicine at Athersys, Inc., from October 2003 to June 2006. He has led Athersys' regenerative medicine research and development activities since February 2003. He is highly regarded as an expert ...

Read Full Background

Corporate Headquarters*

3201 Carnegie Avenue
Cleveland, Ohio 44115

United States

Phone: 216-431-9900
Fax: 216-361-9495

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

Unknown/Other Education
Massachusetts Institute of Technology
PhD
University of Michigan

Other Affiliations*

Annual Compensation*

Salary$326,570
Bonus$55,000
Total Annual Compensation$381,570

Stock Options*

Restricted Stock Awards$76,164
All Other Compensation$10,420
Exercisable Options302,980
Unexercisable Options140,860
Total Number of Options443,840

Total Compensation*

Total Annual Cash Compensation$391,990
Total Short Term Compensation$381,570
Other Long Term Compensation$86,584
Total Calculated Compensation$611,453
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATHX:US $2.86 USD -0.0055

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marc H. Hedrick M.D.Chief Executive Officer, President, Director and Member of Executive Committee
Cytori Therapeutics, Inc.
$437.4K
Martin M. McGlynn Chief Executive Officer, Chief Executive Officer of Stemcells California Inc, President of Stemcells California Inc, Director and Member of Strategic Transactions Committee
StemCells Inc.
$835.8K
David J. Mazzo B.A (Hons), B.Sc. (Hons.), M.Sc., Ph.D.Chief Executive Officer and Director
Neostem, Inc.
--
Paul K. Wotton Ph.D.Chief Executive Officer, President, Director and Member of Pricing Committee
Ocata Therapeutics, Inc.
--
Zami Aberman Executive Chairman and Chief Executive Officer
Pluristem Therapeutics, Inc.
$503.7K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ATHERSYS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.